<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, J.-M.</style></author><author><style face="normal" font="default" size="100%">Alkabbani, W.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Drug Safety</style></title><secondary-title><style face="normal" font="default" size="100%">Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data”</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.scopus.com/inward/record.url?eid=2-s2.0-85152556353&amp;partnerID=MN8TOARS</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>